Phase 3 Lipodystrophy Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

Generalized Lipodystrophy

Regeneron Pharmaceuticals28 enrolled2 locationsNCT07220785

Recruiting

Phase 3

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Familial Partial Lipodystrophy

Amryt Pharma24 enrolled7 locationsNCT06679270

Recruiting

Phase 3

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Generalized Lipodystrophy

Amryt Pharma15 enrolled12 locationsNCT06502990